Title : Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Pub. Date : 2007 Jan 1

PMID : 16960145






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Vorinostat TSPY like 2 Homo sapiens
2 Vorinostat demonstrated activity in heavily pretreated patients with CTCL. Vorinostat TSPY like 2 Homo sapiens